Aim of the study. Assessment of biological features and treatment of patients with breast cancer presenting during pregnancy or lactation. Patients and methods. Immunohistochemical analysis of estrogen receptor (ER) and progesteron receptor (PgR), Ki-67, HER2/neu, prognostic markers, treatment and follow-up of 21 patients with breast cancer during pregnancy (BCdP) and 17 with breast cancer during lactation (BCdL) are presented. Results. Median age was 36 and 33 years, median tumour size was 2.4 and 2.5 cm, axillary lymph nodes were positive in 10 of 21 pregnant patients and 11 of 17 lactating patients, respectively. Both ER and PgR were not expressed in six of 21 pregnant women and nine of 17 lactating patients. All the six women who had concurrent diagnosis of breast cancer and pregnancy (first trimester) preferred termination of pregnancy although an alternative option was discussed. Five patients received antracyclin containing chemotherapy during the second and third trimester with no complications for patient and child. Conservative surgery was performed in 15 of 21 patients during pregnancy with no local reappearance after a median follow-up of 24 months. Three pregnant women underwent lymphoscintigraphy and sentinel lymph node biopsy. Conclusions. Patients who had concurrent diagnosis of breast cancer and pregnancy (early first trimester) preferred termination of pregnancy to allow easier completion of treatment. Conservative surgery was safe also in women with BCdP. Sentinel node biopsy might be considered for pregnant patients with a clinically negative axilla.

Breast cancer diagnosed during pregnancy and lactation : biological features and treatment options / O. Gentilini, M. Masullo, N. Rotmensz, F. Peccatori, G. Mazzarol, A. Smeets, S. Simsek, P. Veronesi, M. Intra, S. Zurrida, G. Viale, A. Goldhirsch, U. Veronesi. - In: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. - ISSN 0748-7983. - 31:3(2005), pp. 232-236. [10.1016/j.ejso.2004.11.01]

Breast cancer diagnosed during pregnancy and lactation : biological features and treatment options

P. Veronesi;S. Zurrida;G. Viale;
2005

Abstract

Aim of the study. Assessment of biological features and treatment of patients with breast cancer presenting during pregnancy or lactation. Patients and methods. Immunohistochemical analysis of estrogen receptor (ER) and progesteron receptor (PgR), Ki-67, HER2/neu, prognostic markers, treatment and follow-up of 21 patients with breast cancer during pregnancy (BCdP) and 17 with breast cancer during lactation (BCdL) are presented. Results. Median age was 36 and 33 years, median tumour size was 2.4 and 2.5 cm, axillary lymph nodes were positive in 10 of 21 pregnant patients and 11 of 17 lactating patients, respectively. Both ER and PgR were not expressed in six of 21 pregnant women and nine of 17 lactating patients. All the six women who had concurrent diagnosis of breast cancer and pregnancy (first trimester) preferred termination of pregnancy although an alternative option was discussed. Five patients received antracyclin containing chemotherapy during the second and third trimester with no complications for patient and child. Conservative surgery was performed in 15 of 21 patients during pregnancy with no local reappearance after a median follow-up of 24 months. Three pregnant women underwent lymphoscintigraphy and sentinel lymph node biopsy. Conclusions. Patients who had concurrent diagnosis of breast cancer and pregnancy (early first trimester) preferred termination of pregnancy to allow easier completion of treatment. Conservative surgery was safe also in women with BCdP. Sentinel node biopsy might be considered for pregnant patients with a clinically negative axilla.
Breast cancer; Conservative surgery; Immunohisto-chemistry; Lactation; Pregnancy; Prognosis; Treatment
Settore MED/18 - Chirurgia Generale
Settore MED/08 - Anatomia Patologica
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/46740
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 43
social impact